Media Coverage

Media articles featuring INFORMS members in the news.

Most Recent Media Coverage

Topic
New Year Starts with Challenges of COVID-19 Vaccine Rollout

New Year Starts with Challenges of COVID-19 Vaccine Rollout

Relias Media, January 1, 2021

Like certain celebrities, the “vaccine” does not need a first name or modifier. Data from both Pfizer and Moderna have shown their COVID-19 vaccines to be nearly 95% effective in preventing disease in people who received two doses, thus earning a green light from the Food and Drug Administration. Other vaccines in clinical trials also are showing promising results. Although vaccine doses have been distributed to all states, limited quantities will force states to prioritize those who should get the first doses.

As COVID-19 Vaccine Rolls Out, Leaders Need to Roll Up Sleeves

As COVID-19 Vaccine Rolls Out, Leaders Need to Roll Up Sleeves

Relias Media, January 1, 2021

The good news toward the end of 2020 was the emergency approval of two COVID-19 vaccines. Like certain celebrities, the “vaccine” did not need a first name or modifier. Everyone heard of the promising data coming out of Pfizer and Moderna, showing the vaccines to be about 95% effective against preventing COVID-19 in people who received two doses. Other vaccines also showed promising results, and the Food and Drug Administration has already given emergency use authorization (EUA) to the Pfizer and Moderna vaccines.

Help Case Managers Overcome Vaccine Hesitancy

Help Case Managers Overcome Vaccine Hesitancy

Relias Media, January 1, 2021

Many Americans and healthcare workers have doubts and skepticism about the first vaccines for COVID-19, despite the need for a rapid end to the pandemic surge that began to overflow hospitals before the December holidays. “The truth is that healthcare workers are not immune from vaccine hesitancy,” says Tinglong Dai, PhD, associate professor of operations management and business analytics at Johns Hopkins University Carey Business School in Baltimore. “It’s a phenomenon with real public health impacts.”

Why is Maryland's COVID-19 Vaccination Rollout So Slow? Some Cite Lack of Central Planning.

Why is Maryland's COVID-19 Vaccination Rollout So Slow? Some Cite Lack of Central Planning.

The Baltimore Sun, January 8, 2021

It was early Dec. 23 when 100 doses of the Moderna COVID-19 vaccine arrived in Baltimore County, and by evening half had been given to health department workers and half to first responders. About 3,400 more Moderna doses arrived a week later, and 6,825 Pfizer doses arrived after that. They have not all been used, though appointments are scheduled to use many of them. “People have to understand, I can’t now just open a clinic and hope I get vaccine,” said Dr. Gregory Branch, the county health officer. “I have to plan once I know how much vaccine I’m getting.”

Making Sense of the Lagging U.S. COVID-19 Vaccination Effort

Making Sense of the Lagging U.S. COVID-19 Vaccination Effort

Hub, January 8, 2021

It's been three weeks since the COVID-19 vaccines began arriving at hospitals, clinics, and pharmacies. Operation Warp Speed—the U.S. vaccination development, testing, and distribution effort—had made 20 million vaccine doses available by the end of 2020. Yet the U.S. is only approaching 5.5 million vaccines administered so far. Public health experts, policymakers, and the leaders of Operation Warp Speed agree: The U.S. must pick up the pace of vaccination.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Artificial Intelligence

Why 23andMe’s Genetic Data Could Be a ‘Gold Mine’ for AI Companies

Why 23andMe’s Genetic Data Could Be a ‘Gold Mine’ for AI Companies

TIME, March 26, 2025

The genetic testing company 23andMe, which holds the genetic data of 15 million people, declared bankruptcy on Sunday night after years of financial struggles. This means that all of the extremely personal user data could be up for sale—and that vast trove of genetic data could draw interest from AI companies looking to train their data sets, experts say.

Healthcare

Want to reduce the cost of healthcare? Start with our billing practices.

Want to reduce the cost of healthcare? Start with our billing practices.

The Hill, March 11, 2025

Robert F. Kennedy Jr., as the new secretary of Health and Human Services, is the nation’s de facto healthcare czar. He will have influence over numerous highly visible agencies, including the Centers for Disease Control and Prevention, the National Institutes of Health and the Food and Drug Administration, among others. Given that healthcare is something that touches everyone’s life, his footprint of influence will be expansive. 

We all benefit from and are hurt by health insurance claim denials

We all benefit from and are hurt by health insurance claim denials

Atlanta Journal Constitution, January 23, 2025

Health insurance has become necessary, with large and unpredictable health care costs always looming before each of us. Unfortunately, the majority of people have experienced problems when using their health insurance to pay for their medical care. Health insurance serves as the buffer between patients and the medical care system, using population pooling to mitigate the risk exposure on any one individual.

Supply Chain

Experts warn logistics industry stakeholders to make contingency plans

Experts warn logistics industry stakeholders to make contingency plans

Seafood Source, March 10, 2025

In their March 2025 forecasts, shipping and logistics experts are warning those who rely on the industry to expect continued disruption, and in order to survive a chaotic landscape, they are advising businesses to spend money conservatively, work with trusted partners, and make comprehensive contingency plans.

Climate